A First-in-human, 3-part Study of MRT-8102 in Healthy Participants and Participants at Cardiovascular Risk With Elevated CRP

NCT07119125 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Elevated CRP

Interventions

DRUG: MRT-8102
DRUG: Placebo

Sponsor

Monte Rosa Therapeutics, Inc